ArticleSarcoma2013

A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.

Robert G Maki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.